Malignant pleural mesothelioma: a phase II trial with docetaxel. [electronic resource]
Producer: 20021104Description: 412-5 p. digitalISSN:- 0923-7534
- Adolescent
- Adult
- Aged
- Antineoplastic Agents, Phytogenic -- adverse effects
- Carcinoma -- drug therapy
- Docetaxel
- Female
- Gastrointestinal Diseases -- chemically induced
- Hematologic Diseases -- chemically induced
- Humans
- Male
- Mesothelioma -- drug therapy
- Middle Aged
- Paclitaxel -- adverse effects
- Pleural Neoplasms -- drug therapy
- Survival Rate
- Taxoids
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.